Citation Impact
Citing Papers
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
2004 StandoutNobel
Triple-negative breast cancer molecular subtyping and treatment progress
2020 Standout
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
2003 Standout
High Frequency of Bone/Bone Marrow Involvement in Advanced Medullary Thyroid Cancer
2005
Angiography-proven liver metastases explain low efficacy of lymph node dissections in medullary thyroid cancer patients
2004
In vivo imaging of gene and cell therapies
2001
Biological Functions of Autophagy Genes: A Disease Perspective
2019 Standout
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging
2009 Standout
Molecular Imaging
2001
Magnetic nanoparticles in MR imaging and drug delivery
2008 Standout
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
DZ-2384 has a superior preclinical profile to taxanes for the treatment of triple-negative breast cancer and is synergistic with anti-CTLA-4 immunotherapy
2018
Computationally Designed Bispecific Antibodies using Negative State Repertoires
2016
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
2009 Standout
Recoil-distance lifetime measurements of levels in 36Ar and 36Cl
1976 StandoutNobel
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Immunoscintigraphy with positron emission tomography: gallium-68 chelate imaging of breast cancer pretargeted with bispecific anti-MUC1/anti-Ga chelate antibodies.
2001
Inelastic electron scattering from low-lying states in the nuclei 36Ar and 40Ar
1977
Sensitivity and Prognostic Value of Positron Emission Tomography with F-18-Fluorodeoxyglucose and Sensitivity of Immunoscintigraphy in Patients with Medullary Thyroid Carcinoma Treated with Anticarcinoembryonic Antigen-Targeted Radioimmunotherapy
2007
Charge-dependent andA
1977
New Strategies for Fluorescent Probe Design in Medical Diagnostic Imaging
2009 Standout
The Ame2012 atomic mass evaluation
2012 Standout
Spectroscopic information on 24Mg and 28Si from proton capture
1990
Energy levels of A = 21−44 nuclei (V)
1973
Abnormal carcinoembryonic antigen levels and medullary thyroid cancer progression: a multivariate analysis.
2007
Radiometal-Labeled Agents (Non-Technetium) for Diagnostic Imaging
1999
Energy levels of A = 21–44 nuclei (VII)
1990
Terrestrial in situ cosmogenic nuclides: theory and application
2001 Standout
Coulomb reorientation of 2+ states in 32S and 112Cd
1971 StandoutNobel
Schematic Model for Isospin Mixing in Light Nuclei
1978 StandoutNobel
Lifetimes of the first four excited states of 32 S
1971
Detection of nucleon correlations via pion double-charge-exchange reactions
1988 StandoutNobel
Advances in Copper Complexes as Anticancer Agents
2013 Standout
TRANSITION PROBABILITY FROM THE GROUND TO THE FIRST-EXCITED 2+ STATE OF EVEN–EVEN NUCLIDES
2001 Standout
Guidelines for the management of thyroid cancer
2014 Standout
Current Update on Medullary Thyroid Carcinoma
2013
Intercalibration of standards, absolute ages and uncertainties in 40Ar/39Ar dating
1998 Standout
Energy levels of A = 21–44 nuclei (VI)
1978 Standout
Alterations of autophagy in the peripheral neuropathy Charcot-Marie-Tooth type 2B
2017
Use of the 14C(18O,12Be)20Ne reaction to measure the mass of 12Be
1974 StandoutNobel
Reconfigurable asymmetric protein assemblies through implicit negative design
2022 StandoutScienceNobel
Inorganic Nanoparticles for MRI Contrast Agents
2009 Standout
Works of F. Leccia being referenced
Cytometric and biochemical characterization of human breast cancer cells reveals heterogeneous myoepithelial phenotypes
2012
ABCG2, a novel antigen to sort luminal progenitors of BRCA1- breast cancer cells
2014
Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA x anti-DTPA-indium bispecific antibody.
1998
Etude de la décroissance β+ de 33Cl
1981
Étude des états excités du noyau 34Cl
1977
Mesures des vies moyennes des premiers état S excités du noyau 36Ar
1970
Étude desétats excités du nouau 35Cl
1972
Étude des résonances de la réaction 31P(p, γ) 32S dans le domaine d'énergie Ep = 1100-1600 keV
1972
Étude des états excités du noyau 34Cl
1977
Mesures des vies moyennes des premiers états excités Du Noyau 28Si
1970
LowestT = 2 Ar 36 Cl 35 ( p , γ ) Ar 36
1976
Mesures des vies moyennes des premiers états excités du noyau 32S
1969
Rapports d'embranchement, vies moyennes et mélanges multipolaires dans le noyau 24Mg
1973
Étude desétats excites du 35Cl
1972